Molecular Partners AG (MLLCF)
OTCMKTS
· Delayed Price · Currency is USD
4.220
-0.060 (-1.40%)
At close: Jan 30, 2025
Molecular Partners AG Employees
Molecular Partners AG had 159 employees as of December 31, 2024. The number of employees decreased by 9 or -5.37% compared to the previous year.
Employees
159
Change (1Y)
-9
Growth (1Y)
-5.37%
Revenue / Employee
$34,494
Profits / Employee
-$375,083
Market Cap
154.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Molecular Partners AG News
- 3 months ago - Molecular Partners: Leveraging Its Biologics Platform Into Early Clinical Programs - Seeking Alpha
- 3 months ago - Molecular Partners & Orano Med join hands for alpha radio-therapies for cancer - Seeking Alpha
- 3 months ago - Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer - GlobeNewsWire
- 4 months ago - Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January - GlobeNewsWire
- 4 months ago - Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024 - GlobeNewsWire
- 6 months ago - Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 - GlobeNewsWire
- 6 months ago - Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going - GlobeNewsWire